QSI

Quantum-Si Inc

$0.82 -0.04 (-4.99%) At close · Jul 16

Market Cap

$179.09M

217,760,163

Up next

Next earnings call

Aug 2, 2026 Est · unconfirmed · in 2 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 7, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Strong Sell Momentum Very Weak Sentiment Bullish Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 16.7 · calm Equity put/call 0.67

Technical

price trend

Strong Sell

50 / 200-day cross No cross

Price vs 200-day avg −31%

below

Price vs 50-day avg −16%

below

RSI (14) 38

neutral

MACD trend Negative

52-week position 5%

near low

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −14%

trailing

6-month return −37%

trailing

YTD return −26%

this year

Relative strength −46%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $1 › 200d $1 — 200d above 50d

Institutional flow Accumulating

10 of 156 funds reported for Jun 30 · net +54.1K sh shares · +1 new

Insider flow Distributing

Net -$313.5K over 90 days · 100% sells

Short interest Falling

7.99% of float · ▼ -22.7% MoM · 2.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

156 holders — near 3-yr high, broad support

Squeeze score 58

elevated · 0–100

Fundamentals

Strong

Revenue growth −20%

Y/Y

Gross margin 47%

contracting

EPS growth +28%

Y/Y

Free cash flow $-97.2M

Balance sheet $21.6M

net cash

Quant / Vol

risk profile

Very High

Volatility 91%

annualized · 1-yr

Max drawdown −73%

past year

ATR 8.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record what management promised — and delivered

Latest guidance · from the 8-K filed May 7, 2026

Revenue · full year 2026 Initiated $1M

prior FY $2.44M midpoint −58.9% Y/Y

Adjusted total operating expenses · full year 2026 Non-GAAP Initiated up to $98M

Total cash usage · full year 2026 Initiated up to $93M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell

4 · 3 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−31% Bearish

Price vs 50-day avg

−16% Bearish

RSI (14)

38 Neutral

MACD trend

Negative Bearish

52-week position

5% Bearish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $1 › 200d $1 — 200d above 50d

Institutional flow Accumulating

10 of 156 funds reported for Jun 30 · net +54.1K sh shares · +1 new

Insider flow Distributing

Net -$313.5K over 90 days · 100% sells

Short interest Falling

7.99% of float · ▼ -22.7% MoM · 2.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

156 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $1 Now $1 · 5% 52-wk high $3

vs 200-day avg -31% vs 50-day avg -16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Adjusted EBITDA non-GAAP	-$20.1M	first quarter of 2026	—
Adjusted total operating expenses non-GAAP	$21.4M	first quarter of 2026	—

Proteus list price	$425,000	announcement as of March 3, 2026	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
QSI Quantum-Si Inc this stock	$179.09M	-25.5%	-20.3%	—	8.0%
ABT Abbott Laboratories	$175.37B	-20.7%	+5.7%	28.2	1.3%
SYK Stryker Corp	$126.97B	-5.5%	+11.2%	38.3	1.8%
MDT Medtronic plc	$106.96B	-12.3%	+8.4%	22.4	1.5%
BSX Boston Scientific Corp	$66.32B	-53.2%	+5.5%	18.7	1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

157

% held: 28.8%
Reported: 10 of 156
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

17.4M

Days to cover: 2.7d
Change: -5.1M sh

View

Short Volume

Short vol %

52%

As of: Jul 17, 2026

Short Total

View

Fails to Deliver

FTD shares

112.4K

Value: $100.0K
As of: Jun 30, 2026

View

Off-Exchange

Off-exchange %

76.3%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$313.5K

Buyers / Sellers: 0 / 4

Buyers Sellers

View

Financials

Revenue (FY)

$2.4M

Net income (FY): $-101.3M
EPS diluted: $-0.51

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Jun 30, 2026
This year: 8

View

Proposed Sales

Value

$21.0K

Shares: 22.6K
Filed: Jun 24, 2026

View

Earnings & Events

Earnings Calls

Last call

May 19, 2026

View

Performance

	5D	20D	120D	MTD	YTD
QSI	-14.9%	-14.2%	-37.5%	-7.5%	-25.6%
SPY	-0.1%	+0.1%	+9.0%	+0.5%	+10.1%
vs SPY	-14.7%	-14.2%	-46.4%	-8.0%	-35.6%

Key facts CIK 1816431 CUSIP 74765K105 13F (30d) 10 filings 10 filers Visit website Investor relations

QSI

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance